6514 ORAL Adjuvant therapy in stage IB/II non-small cell lung cancer (NSCLC): final results of a multi-center, double-blind, randomized, placebo-controlled Phase II study evaluating the MAGE-A3 cancer immunotherapeutic

J. Vansteenkiste; M. Zielinski; A. Linder; J. Dahabre; E. Esteban; W. Malinowski; J. Jassem; B. Passlick; M. López-Brea; T. Vanakesa

doi:10.1016/s1359-6349(07)71342-3

6514 ORAL Adjuvant therapy in stage IB/II non-small cell lung cancer (NSCLC): final results of a multi-center, double-blind, randomized, placebo-controlled Phase II study evaluating the MAGE-A3 cancer immunotherapeutic

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(07)71342-3 ◽

2007 ◽

Vol 5 (4) ◽

pp. 361 ◽

Cited By ~ 4

Author(s):

J. Vansteenkiste ◽

M. Zielinski ◽

A. Linder ◽

J. Dahabre ◽

E. Esteban ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Double Blind ◽

Cancer Immunotherapeutic

Download Full-text

B1-05: Activity of MAGE-A3 cancer immunotherapeutic as adjuvant therapy in stage IB/II non-small cell lung cancer (NSCLC): final results of a multi-center, double-blind, randomized, placebo-controlled phase II study

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283143.53176.59 ◽

2007 ◽

Vol 2 (8) ◽

pp. S334-S335 ◽

Cited By ~ 4

Author(s):

Johan Vansteenkiste ◽

Marcin Zielinksi ◽

Albert Linder ◽

Jubrail Dahabre ◽

Emilio Esteban ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Double Blind ◽

Cancer Immunotherapeutic

Download Full-text

Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study

Advances in Therapy ◽

10.1007/s12325-020-01538-0 ◽

2020 ◽

Author(s):

Lowell L. Hart ◽

Renata Ferrarotto ◽

Zoran G. Andric ◽

J. Thaddeus Beck ◽

Janakiraman Subramanian ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1158694.618908 ◽

2009 ◽

Author(s):

Ross Cagan

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Double Blind ◽

Randomized Phase Ii

Download Full-text

Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(16)00099-1 ◽

2016 ◽

Vol 17 (6) ◽

pp. 822-835 ◽

Cited By ~ 192

Author(s):

Johan F Vansteenkiste ◽

Byoung Chul Cho ◽

Tonu Vanakesa ◽

Tommaso De Pas ◽

Marcin Zielinski ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Small Cell Lung ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Cancer Immunotherapeutic

Download Full-text

Phase II study of postoperative adjuvant therapy in patients with completely resected stage II and IIIA non-small cell lung cancer (RTOG 97-05)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(01)01865-x ◽

2001 ◽

Vol 51 (3) ◽

pp. 23-24

Author(s):

D.S. Ettinger ◽

C. Hsu ◽

J. Bradley ◽

M.V. Pilepich ◽

M. Machtay ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Postoperative Adjuvant Therapy ◽

Small Cell Lung ◽

Resected Stage

Download Full-text

A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC)

Annals of Oncology ◽

10.1093/annonc/mdt212 ◽

2013 ◽

Vol 24 (9) ◽

pp. 2382-2389 ◽

Cited By ~ 36

Author(s):

H.J.M. Groen ◽

M.A. Socinski ◽

F. Grossi ◽

E. Juhasz ◽

C. Gridelli ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Line Treatment ◽

Second Line ◽

Small Cell Lung ◽

Double Blind

Download Full-text

P2.06-019 A Phase II Study of Atezolizumab as Neoadjuvant and Adjuvant Therapy in Patients (pts) with Resectable Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2016.11.1512 ◽

2017 ◽

Vol 12 (1) ◽

pp. S1082

Author(s):

Dwight Owen ◽

Paul Bunn ◽

Bruce Johnson ◽

David Kwiatkowski ◽

Mark Kris ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung

Download Full-text

Magrit, a Double-Blind, Randomized, Placebo-Controlled Phase III Study to Assess the Efficacy of the Recmage-A3 + As15 Cancer Immunotherapeutic As Adjuvant Therapy in Patients with Resected Mage-A3-Positive Non-Small Cell Lung Cancer (Nsclc)

Annals of Oncology ◽

10.1093/annonc/mdu347.1 ◽

2014 ◽

Vol 25 ◽

pp. iv409 ◽

Cited By ~ 24

Author(s):

J.F. Vansteenkiste ◽

B. Cho ◽

T. Vanakesa ◽

T. De Pas ◽

M. Zielinski ◽

...

Keyword(s):

Lung Cancer ◽

Adjuvant Therapy ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Small Cell Lung ◽

Double Blind ◽

Phase Iii Study ◽

Cancer Immunotherapeutic

Download Full-text

Final Results of a Randomized, Double-Blind Phase II Study to Compare Nitroglycerin (N) Plus Oral Vinorelbine (NVBO) Plus Cisplatin (C) with Placebo (P) Plus NVBO Plus C in Patients (Pts) with Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)

Annals of Oncology ◽

10.1016/s0923-7534(20)33842-4 ◽

2012 ◽

Vol 23 ◽

pp. ix409-ix410

Author(s):

M. Reck ◽

A. Meyer ◽

D. Hartwigsen ◽

C. Schaeper ◽

R. Skock-Lober ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iiib ◽

Small Cell Lung ◽

Double Blind ◽

Oral Vinorelbine

Download Full-text

Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/j.lungcan.2014.01.001 ◽

2014 ◽

Vol 83 (3) ◽

pp. 363-368 ◽

Cited By ~ 23

Author(s):

N. Reinmuth ◽

A. Meyer ◽

D. Hartwigsen ◽

C. Schaeper ◽

G. Huebner ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Stage Iiib ◽

Small Cell Lung ◽

Double Blind ◽

Oral Vinorelbine

Download Full-text